Jones Financial Companies
MDGL icon

Jones Financial Companies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jones Financial Companies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
2,257
+963
+74% +$493K ﹤0.01% 1822
2026
Q1 		$661K Buy
1,294
+1,095
+550% +$523K ﹤0.01% 1908
2025
Q4 		$116K Hold
199
– – ﹤0.01% 2163
2025
Q3 		$84.4K Buy
199
+3
+2% +$1.12K ﹤0.01% 2144
2025
Q2 		$58.9K Buy
196
+32
+20% +$9.53K ﹤0.01% 2154
2025
Q1 		$53.8K Buy
164
+142
+645% +$46.7K ﹤0.01% 2029
2024
Q4 		$6.79K Sell
22
-14
-39% -$3.94K ﹤0.01% 2665
2024
Q3 		$7.65K Sell
36
-299
-89% -$76.5K ﹤0.01% 2316
2024
Q2 		$93.9K Buy
+335
New +$79.7K ﹤0.01% 1070

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jones Financial Companies's MDGL Position: Q2 2026 in Review

Jones Financial Companies increased its Madrigal Pharmaceuticals (MDGL) stake by 74% in Q2 2026, buying an estimated $493K and bringing the position to 2,257 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Jones Financial Companies first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Jones Financial Companies held 2,257 shares of Madrigal Pharmaceuticals worth $1.16M as of Q2 2026.
  • Jones Financial Companies bought 963 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $493K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1822 holding.
  • Jones Financial Companies first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.